Committee for Medicinal Products for Human Use (CHMP) meeting highlights
A summary of the CHMP meeting conclusions, including medicines recommended for approval and indication extension and several safety review findings.
List view / Grid view
A summary of the CHMP meeting conclusions, including medicines recommended for approval and indication extension and several safety review findings.
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).